Discover
NVCT
Nuvectis Pharma, Inc.
18.48
2 x 13.47
2 x 23.56
bid
ask
-
0.09
0.48%
2 @ 04:00 PM
18.48 +0.00 (0.00%)
| Ytd | 144.77% | |
| 1y | 178.31% |
18.20
day range
18.92
5.55
52 week range
29.27
| Open | 18.46 | Prev Close | 18.57 | Low | 18.20 | High | 18.92 | Mkt Cap | 603.26M |
| Vol | 167.18K | Avg Vol | 199.37K | EPS | -1.31 | P/E | N/A | Forward P/E | -4.77 |
| Beta | 0.40 | Short Ratio | 5.30 | Inst. Own | 6.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 21.55 | 200-d Avg | 14.56 | 1yr Est | 22.00 |
| Income Statement | |||
| Operating Expenses | 7.20M | ||
| Research and Development Expense | 4.68M | ||
| Selling, General and Administrative Expense | 2.51M | ||
| Operating Income | -7.20M | ||
| Net Income | -7.02M | ||
| Net Income Common Stock | -7.02M | ||
| Net Income Common Stock (USD) | -7.02M | ||
| Consolidated Income | -7.02M | ||
| Earnings per Basic Share | -0.30 | ||
| Earnings per Basic Share (USD) | -0.30 | ||
| Earnings per Diluted Share | -0.30 | ||
| Earning Before Interest & Taxes (EBIT) | -7.02M | ||
| Earning Before Interest & Taxes (USD) | -7.02M | ||
| Weighted Average Shares | 23.48M | ||
| Weighted Average Shares Diluted | 23.48M | ||
| Balance Sheet | |||
| Cash and Equivalents | 22.16M | ||
| Cash and Equivalents (USD) | 22.16M | ||
| Current Assets | 22.38M | ||
| Total Assets | 22.38M | ||
| Current Liabilities | 13.29M | ||
| Total Liabilities | 13.29M | ||
| Accumulated Retained Earnings (Deficit) | -112.76M | ||
| Shareholders Equity | 9.08M | ||
| Shareholders Equity (USD) | 9.08M | ||
| Trade and Non-Trade Payables | 5.18M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 1.56M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.97M | ||
| Issuance (Purchase) of Equity Shares | 1.56M | ||
| Net Cash Flow from Operations | -4.53M | ||